Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Evidence for a multiple sclerosis epidemic?
A simple score for estimating the long-term risk of fracture in patients with multiple sclerosis.
Epstein-Barr virus neuraxis infection as a trigger for central nervous system demyelinating processes: a case report.
A Sphingosine-1-Phosphate Receptor 1-Directed Agonist Reduces Central Nervous System Inflammation in a Plasmacytoid Dendritic Cell-Dependent Manner.
Serum antibodies to 25 myelin oligodendrocyte glycoprotein epitopes in multiple sclerosis and neuromyelitis optica: clinical value for diagnosis and disease activity.
Genetic predictors of relapse rate in pediatric MS.
Chondroitin 6-O-sulfate ameliorates experimental autoimmune encephalomyelitis.
Mitochondrial mutations of Leber's hereditary optic neuropathy: a risk factor for multiple sclerosis.
Stereotactic neurosurgery for disabling tremor in multiple sclerosis: thalamotomy or deep brain stimulation?
Induction of Heat Shock Protein 70 (Hsp70) prevents neuregulin-induced demyelination by enhancing the proteasomal clearance of c-Jun.
Evaluating risks, costs, and benefits of new and emerging therapies to optimize outcomes in multiple sclerosis.
Multiple sclerosis decreases explicit counterfactual processing and risk taking in decision making.
The potential role of T cell migration and chemotaxis as targets of glucocorticoids in multiple sclerosis and experimental autoimmune encephalomyelitis.
Computer-based diagnosis of illness in historical persons.
Immunology: B-cell development in the gut.
Similar genetics of adult and pediatric MS: Age is just a number.
Goal attainment in cognitive rehabilitation in MS patients.
Human glial chimeric mice reveal astrocytic dependence of JC virus infection.
Natalizumab as a Disease-Modifying Therapy in Chronic Inflammatory Demyelinating Polyneuropathy - A Report of Three Cases.
Dual Inhibition of IL-23 and IL-17 Offers Superior Efficacy in Mouse Models of Autoimmunity.
Polymorphisms of the CD24 Gene Are Associated with Risk of Multiple Sclerosis: A Meta-Analysis.
Is dosing of therapeutic immunoglobulins optimal? A review of a three-decade long debate in europe.
Lhermitte's Sign: The Current Status.
Barriers and Facilitators Related to Rehabilitation Stays in Multiple Sclerosis: A Qualitative Study.
[Characteristics of the autonomous control of cardiac activity in patients with remitting multiple sclerosis.]

Pages